Viral Products

Integrated CDMO and Testing services for viral products used in the production of biopharmaceuticals are designed to expedite time to clinic and support commercial programs around the world. By leveraging over three decades of virology expertise, we offer the following:
  • Expedited tech transfer
  • FDA Registered facilities
  • Integrated manufacturing and testing including genetic sequencing, adventitious agent screening, and stability studies
  • Process and Analytical Development
  • Scalable capacity
  • Global regulatory support

Virus experience includes:

  • Lentivirus
  • Retrovirus
  • Adeno-Associated Virus (AAV)
  • Adenovirus

Learn more

Set up a call with our experts.

Master and Working Viral Banks

Pure viral seeds, more than starting materials used to create viral banks, they serve as the foundation for assessing the lifetime quality of your biopharmaceutical. We offer full service solutions from master viral bank creation to drug product lot release including complete characterization of genetic and phenotypic stability.



Oncolytic Viruses

An emerging “dual threat” in the fight against cancer, oncolytic viruses are utilized as either a monotherapy or combined with existing checkpoint inhibitors/T cell therapies to provide an enhanced therapeutic response. Since 2015, we have committed significant financial resources to create the necessary manufacturing and testing infrastructure needed to facilitate rapid development.




Viral Vector Manufacturing and Testing      

Our integrated manufacturing and testing platform for viral vectors supplies clients with GMP materials faster and with greater predictability, expediting entry to first in human clinical trials.

Request a Proposal

Discuss feasibility and the potential for accelerated timelines with our technical team.

Browse Additional Services